Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOSEPH B PARUOLO

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1639461742
CMS profile
1391710
Location
BRANDON, FL

General Payments · PY2018–2024

$796.45

  • Reported across 21 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$356.28

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $356.28 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ViiV Healthcare Company $242.94 11
Gilead Sciences, Inc. $87.39 3
Merck Sharp & Dohme Corporation $25.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $198.85 3
PY2019 $15.05 1
PY2020 $114.88 1
PY2021 $111.39 1
PY2024 $356.28 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920202021 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Gilead Sciences, Inc. $32.82 05/22/2024 Food and Beverage Undisputed 01/23/2026 1133759586 CMS
Gilead Sciences, Inc. $31.37 05/30/2024 Food and Beverage Undisputed 01/23/2026 1133759588 CMS
Gilead Sciences, Inc. $23.20 06/13/2024 Food and Beverage Undisputed 01/23/2026 1133759590 CMS
Merck Sharp & Dohme LLC $25.95 06/27/2024 Food and Beverage Undisputed 01/23/2026 1141624055 CMS
ViiV Healthcare Company $23.30 04/24/2024 Food and Beverage Undisputed 01/23/2026 1112775888 CMS
ViiV Healthcare Company $15.45 05/02/2024 Food and Beverage Undisputed 01/23/2026 1112701239 CMS
ViiV Healthcare Company $20.75 05/09/2024 Food and Beverage Undisputed 01/23/2026 1112800447 CMS
ViiV Healthcare Company $19.96 05/16/2024 Food and Beverage Undisputed 01/23/2026 1112824549 CMS
ViiV Healthcare Company $28.05 05/17/2024 Food and Beverage Undisputed 01/23/2026 1112750814 CMS
ViiV Healthcare Company $24.41 05/21/2024 Food and Beverage Undisputed 01/23/2026 1112751970 CMS
ViiV Healthcare Company $18.55 06/26/2024 Food and Beverage Undisputed 01/23/2026 1112798380 CMS
ViiV Healthcare Company $18.86 07/10/2024 Food and Beverage Undisputed 01/23/2026 1112704630 CMS
ViiV Healthcare Company $32.55 07/16/2024 Food and Beverage Undisputed 01/23/2026 1112752274 CMS
ViiV Healthcare Company $17.15 07/25/2024 Food and Beverage Undisputed 01/23/2026 1112709056 CMS
ViiV Healthcare Company $23.91 07/30/2024 Food and Beverage Undisputed 01/23/2026 1112771918 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.